Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/06/1998 | WO1998016507A3 New heterocyclylmethyl-substituted pyrazol derivates and their use for treating cardiovascular diseases |
08/06/1998 | WO1998015275A3 Method and potentiated composition for treating migraine |
08/06/1998 | WO1998010767A3 Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
08/06/1998 | WO1998002148A3 Pharmaceutical composition |
08/06/1998 | DE19704244A1 5-Hydroxy-alkyl substituierte Phenyle 5-hydroxy-alkyl-substituted phenyls |
08/06/1998 | DE19704243A1 Neue 2-Amino-substituierte Pyridine New 2-amino-substituted pyridines |
08/06/1998 | CA2622476A1 System, method and composition for dialysis and shock treatment |
08/06/1998 | CA2280096A1 Nanomolar, non-peptide inhibitors of cathepsin d |
08/06/1998 | CA2280093A1 Compositions and methods for prevention and treatment of vascular degenerative diseases |
08/06/1998 | CA2279947A1 Drugs for memory enhancement |
08/06/1998 | CA2279594A1 Calcareous material |
08/06/1998 | CA2279548A1 Ribozymes cleaving epidermal growth factor receptors |
08/06/1998 | CA2279544A1 Induction of b cell tolerance |
08/06/1998 | CA2279348A1 System, method and composition for dialysis and shock treatment |
08/06/1998 | CA2279326A1 Use of 1-[4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1yl]-2-(6,7-dimethoxynapht-2-yl)ethane for preparing medicines for the treatment of cerebral and neuronal disorders |
08/06/1998 | CA2279259A1 Pain reducing parenteral liposome formulation |
08/06/1998 | CA2279214A1 Antiviral agents |
08/06/1998 | CA2279207A1 Novel compounds |
08/06/1998 | CA2279178A1 Endothelin antagonists: n-[[2'-[ [(4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide and salts thereof |
08/06/1998 | CA2278931A1 Cysteine-depleted peptides recognized by a3-restricted cytotoxic lymphocytes, and uses therefor |
08/06/1998 | CA2278790A1 Sulphonamide derivatives |
08/06/1998 | CA2278190A1 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use thereof |
08/06/1998 | CA2277965A1 Dihydropyrimidone derivatives as npy antagonists |
08/06/1998 | CA2277362A1 Substituted perylenequinones for use in photodynamic therapy |
08/06/1998 | CA2271157A1 Pyrido[2,3-d]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation |
08/06/1998 | CA2251036A1 Use of a polypeptide as cell receptor for adenoviruses |
08/06/1998 | CA2251024A1 Method for preparing substituted anthraquinone and application to the preparation of rheins |
08/05/1998 | EP0856579A1 An antisense oligonucleotide preparation method |
08/05/1998 | EP0856531A2 Granular polybutadiene or polyisoprene |
08/05/1998 | EP0856530A2 Polymerisation catalyst |
08/05/1998 | EP0856514A1 8-substituted-1,3,8-triazaspiro[4.5]decan-4-on derivatives |
08/05/1998 | EP0856513A2 Thalidomide analogues from the piperidine-2,6-dione class |
08/05/1998 | EP0856512A2 1-deoxy paclitaxels, method of preparation and pharmaceutical use |
08/05/1998 | EP0856511A1 Calcium salt of indomethacin pentahydrate and its preparation |
08/05/1998 | EP0856344A1 Process for purifying imidazoles and imidazol-based agents by crystallisation |
08/05/1998 | EP0856318A1 Cyanoacrylate compositions comprising an antimicrobial agent |
08/05/1998 | EP0856316A1 Method for solubilizing pyridonecarboxylic acid, solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid |
08/05/1998 | EP0856313A1 Controlled absorption diltiazem formulations |
08/05/1998 | EP0856312A1 Use of trospium chloride for the manufacture of a medicament for the treatment of diseases of the bladder |
08/05/1998 | EP0856311A1 Transdermal drug delivery system for the treatment of heart diseases |
08/05/1998 | EP0856157A1 Tumour-specific p450 protein |
08/05/1998 | EP0856062A2 Herpesvirus vectors and their uses |
08/05/1998 | EP0856056A1 Fibronectic binding protein b compounds |
08/05/1998 | EP0856051A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
08/05/1998 | EP0856050A1 Transforming growth factor alpha hi |
08/05/1998 | EP0856009A1 Cd6 ligand |
08/05/1998 | EP0856007A1 Cyclopeptide derivatives |
08/05/1998 | EP0856005A1 The aiolos gene |
08/05/1998 | EP0856002A1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
08/05/1998 | EP0856001A1 Pyrimidine derivatives as 5ht 2c?-receptor antagonists |
08/05/1998 | EP0856000A1 1,3,5-trisubstituted pyrazoles for treament of inflammation |
08/05/1998 | EP0855999A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
08/05/1998 | EP0855919A1 Hormone immunomodulated induction of mucosal immune responses |
08/05/1998 | EP0855918A1 Chicken interleukin-15 and uses thereof |
08/05/1998 | EP0855917A1 Stable pharmaceutical forms of administration containing parathormone |
08/05/1998 | EP0855916A1 Pharmaceutical composition containing an activin or inhibin stimulator |
08/05/1998 | EP0855914A1 Stable formulations of mhc-peptide complexes |
08/05/1998 | EP0855913A1 Iron dextran formulations |
08/05/1998 | EP0855912A1 Nitrogen monoxide composition for use as a drug |
08/05/1998 | EP0855911A1 Namenamicin, an enediyne antitumor antibiotic from the marine ascidian polysyncraton lithostrotum |
08/05/1998 | EP0855910A1 Conjugates useful in the treatment of benign prostatic hyperplasia |
08/05/1998 | EP0855909A1 Radiosensitizing taxanes and their pharmaceutical preparations |
08/05/1998 | EP0855908A1 Dietary regimen of nutritional supplements for relief of symptoms of arthritis |
08/05/1998 | EP0855906A1 Insoluble drug delivery |
08/05/1998 | EP0831819A4 Method for inhibiting neoplastic disease in mammals |
08/05/1998 | EP0766687B1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
08/05/1998 | EP0752990B1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis |
08/05/1998 | EP0725644B1 Use of budesonide for the preparation of a medicament for the treatment of conditions associated with reduced enteral fluid resorption |
08/05/1998 | EP0700294B1 Intramuscular and subcutaneous injection solution for animals |
08/05/1998 | EP0698019B1 Novel aromatic nitro compounds and their metabolites useful as anti-viral and anti-tumor agents |
08/05/1998 | EP0694080A4 Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome |
08/05/1998 | EP0675711B1 Atovaquone pharmaceutical compositions |
08/05/1998 | EP0674510B1 Injectable composition comprising paclitaxel |
08/05/1998 | EP0674505B1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails |
08/05/1998 | EP0649407B1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
08/05/1998 | EP0642518B1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism |
08/05/1998 | EP0641342B1 Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines |
08/05/1998 | EP0636021B1 Psychoactive propargylamine derivatives |
08/05/1998 | EP0575430B1 Preparation of a medicament for the treatment of addiction to drugs and substances of abuse |
08/05/1998 | EP0553263B1 1'-aminospiro-[isoquinoline-4(1h),3'-pyrrolidine]- 1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo |
08/05/1998 | CN1189857A Recombinant MVA virus, and the use thereof |
08/05/1998 | CN1189837A Peptide and method of obtaining it |
08/05/1998 | CN1189834A Condesned thiazole derivatives, having 5-HT receptor affinity |
08/05/1998 | CN1189833A Amidine derivatives useful as anti-platelet aggreation inhibitors and vasodilators |
08/05/1998 | CN1189832A Diazepino-indoles as phosphodiesterase IV inhibitors |
08/05/1998 | CN1189831A Imidazopyridine derivatives |
08/05/1998 | CN1189829A Piperazino derivatives as neurokinin antagonists |
08/05/1998 | CN1189823A Cyclic amidino agents useful as nitric oxide synthase inhibitors |
08/05/1998 | CN1189821A Substituted oximes, hydrazones and olefins as neurokinin antagonists |
08/05/1998 | CN1189776A High-dose chromic tripicolinate for the treatment of type II diabetes |
08/05/1998 | CN1189775A Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
08/05/1998 | CN1189773A Sterile ophthalmological gel prepn. applicable in drops and processfor producing it |
08/05/1998 | CN1189500A Process of preparing etoposide phosphate and etoposide |
08/05/1998 | CN1189499A Process of preparing etoposide phosphate and etoposide |
08/05/1998 | CN1189497A Process of preparing etoposide phosphate and etoposide |
08/05/1998 | CN1189496A New physical form of artemisinin and its use in production of pharmaceuticals |
08/05/1998 | CN1189491A Isoxazole and crotonamide derivatives and their use as pharmaceuticals and disgnositics |
08/05/1998 | CN1189490A Process for preparing 1-biphenylmethylimidazole derivatives |
08/05/1998 | CN1189340A Novel grand spectrum anti-virus application of Gerd mycomycin |
08/05/1998 | CN1189339A Pharmaceutical compositions containing pyrrolopyrimidines derivatives |